Recent Publications
Palmitoyl acyltransferase ZDHHC7 inhibits androgen receptor and suppresses prostate cancer.
Lin Z, Agarwal S, Tan S, Shi H, Lu X, Tao Z, Dong X, Wu X, Zhao JC, Yu J.Oncogene. 2023 May 17. doi: 10.1038/s41388-023-02718-2. Online ahead of print.
A novel approach to overcome drug resistance in acute myeloid leukemia.
Mazewski C, Platanias LC.Haematologica. 2023 May 11. doi: 10.3324/haematol.2023.283099. Online ahead of print.
MNK Proteins as Therapeutic Targets in Leukemia.
Mazewski C, Platanias LC.Onco Targets Ther. 2023 Apr 21;16:283-295. doi: 10.2147/OTT.S370874. eCollection 2023.
- Morgan MAJ, Shilatifard A.
Sci Adv. 2023 Apr 21;9(16):eadg6593. doi: 10.1126/sciadv.adg6593. Epub 2023 Apr 21.
CD95/Fas ligand mRNA is toxic to cells through more than one mechanism.
Haluck-Kangas A, Fink M, Bartom ET, Peter ME.Mol Biomed. 2023 Apr 15;4(1):11. doi: 10.1186/s43556-023-00119-1.
Regulation of nucleotide metabolism in cancers and immune disorders.
Ali ES, Ben-Sahra I.Trends Cell Biol. 2023 Mar 24:S0962-8924(23)00044-2. doi: 10.1016/j.tcb.2023.03.003. Online ahead of print.
- Bernasek SM, et al. Among authors: carthew rw.
Development. 2023 Apr 15;150(8):dev201467. doi: 10.1242/dev.201467. Epub 2023 Apr 24.
- Soliman SHA, et al. Among authors: shilatifard a.
Sci Adv. 2023 Mar 10;9(10):eadf2468. doi: 10.1126/sciadv.adf2468. Epub 2023 Mar 8.
CXCR7 as a novel therapeutic target for advanced prostate cancer.
Gritsina G, Yu J.Oncogene. 2023 Mar;42(11):785-792. doi: 10.1038/s41388-023-02597-7. Epub 2023 Feb 9.
- Jiang Y, Xu Y, Zheng C, Ye L, Jiang P, Malik S, Xu G, Zhou Q, Zhang M.
Gut. 2023 Feb 8:gutjnl-2022-327853. doi: 10.1136/gutjnl-2022-327853. Online ahead of print.